These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20036319)

  • 1. Residual factor VIII-like cofactor activity of thioredoxin and related oxidoreductases.
    Bayele HK; Murdock PJ; Pasi KJ
    Biochim Biophys Acta; 2010 Mar; 1800(3):398-404. PubMed ID: 20036319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate binding studies of the substrate (factor X) with the cofactor (factor VIII) in the assembly of the factor X activating complex on the activated platelet surface.
    Ahmad SS; Walsh PN
    Biochemistry; 2002 Sep; 41(37):11269-76. PubMed ID: 12220193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
    Mertens K; van Wijngaarden A; Bertina RM
    Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit structure and function of porcine factor Xa-activated factor VIII.
    Parker ET; Pohl J; Blackburn MN; Lollar P
    Biochemistry; 1997 Aug; 36(31):9365-73. PubMed ID: 9235979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor as a regulator of intrinsic factor X activation.
    Koppelman SJ; Koedam JA; van Wijnen M; Stern DM; Nawroth PP; Sixma JJ; Bouma BN
    J Lab Clin Med; 1994 Apr; 123(4):585-93. PubMed ID: 8145007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Glu113Ala mutation within a factor VIII Ca2+-binding site enhances cofactor interactions in factor Xase.
    Wakabayashi H; Su YC; Ahmad SS; Walsh PN; Fay PJ
    Biochemistry; 2005 Aug; 44(30):10298-304. PubMed ID: 16042406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.
    Swieringa F; Kuijpers MJ; Lamers MM; van der Meijden PE; Heemskerk JW
    Haematologica; 2015 Jun; 100(6):748-56. PubMed ID: 25769543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.
    Mertens K; Donath MJ; van Leen RW; de Keyzer-Nellen MJ; Verbeet MP; Klaasse Bos JM; Leyte A; van Mourik JA
    Br J Haematol; 1993 Sep; 85(1):133-42. PubMed ID: 8251380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Escherichia coli thioredoxin variants mimicking the active-sites of other thiol/disulfide oxidoreductases.
    Mössner E; Huber-Wunderlich M; Glockshuber R
    Protein Sci; 1998 May; 7(5):1233-44. PubMed ID: 9605329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant effects of a synthetic peptide containing residues Thr-2253-Gln-2270 within factor VIII C2 domain that selectively inhibits factor Xa-catalysed factor VIII activation.
    Nogami K; Shima M; Nishiya K; Hosokawa K; Saenko EL; Giddings JC; Tanaka I; Yoshioka A
    Br J Haematol; 2002 Mar; 116(4):868-74. PubMed ID: 11886394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic catalysis of disulfide formation.
    Noiva R
    Protein Expr Purif; 1994 Feb; 5(1):1-13. PubMed ID: 7909462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
    Wong MY; Gurr JA; Walsh PN
    Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of DsbA deficiency with secreted thioredoxin variants reveals the crucial role of an efficient dithiol oxidant for catalyzed protein folding in the bacterial periplasm.
    Jonda S; Huber-Wunderlich M; Glockshuber R; Mössner E
    EMBO J; 1999 Jun; 18(12):3271-81. PubMed ID: 10369668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glutaredoxin and protein disulfide isomerase on the glutathione-dependent folding of ribonuclease A.
    Ruoppolo M; Lundström-Ljung J; Talamo F; Pucci P; Marino G
    Biochemistry; 1997 Oct; 36(40):12259-67. PubMed ID: 9315864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single dipeptide sequence modulates the redox properties of a whole enzyme family.
    Huber-Wunderlich M; Glockshuber R
    Fold Des; 1998; 3(3):161-71. PubMed ID: 9562546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
    Misenheimer TM; Buyue Y; Sheehan JP
    Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human factor VIII in factor X activation.
    Hultin MB
    J Clin Invest; 1982 Apr; 69(4):950-8. PubMed ID: 6804496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.